- Home
- SWI vs HRMY Comparison
SWI vs HRMY Comparison
Compare SWI & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWI
- HRMY
- Stock Information
- Founded
- SWI 1999
- HRMY 2017
- Country
- SWI United States
- HRMY United States
- Employees
- SWI N/A
- HRMY N/A
- Industry
- SWI Computer Software: Prepackaged Software
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- SWI Technology
- HRMY Health Care
- Exchange
- SWI Nasdaq
- HRMY Nasdaq
- Market Cap
- SWI 2.3B
- HRMY 1.9B
- IPO Year
- SWI 2009
- HRMY 2020
- Fundamental
- Price
- SWI $13.13
- HRMY $32.78
- Analyst Decision
- SWI Hold
- HRMY Buy
- Analyst Count
- SWI 6
- HRMY 9
- Target Price
- SWI $13.83
- HRMY $47.00
- AVG Volume (30 Days)
- SWI 620.7K
- HRMY 1.2M
- Earning Date
- SWI 10-31-2024
- HRMY 10-29-2024
- Dividend Yield
- SWI N/A
- HRMY N/A
- EPS Growth
- SWI N/A
- HRMY N/A
- EPS
- SWI 0.22
- HRMY 2.11
- Revenue
- SWI $784,725,000.00
- HRMY $681,879,000.00
- Revenue This Year
- SWI $5.08
- HRMY $24.63
- Revenue Next Year
- SWI $3.04
- HRMY $18.04
- P/E Ratio
- SWI $58.60
- HRMY $15.57
- Revenue Growth
- SWI 4.96
- HRMY 25.83
- 52 Week Low
- SWI $10.14
- HRMY $27.97
- 52 Week High
- SWI $14.03
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- SWI 48.56
- HRMY 44.22
- Support Level
- SWI $12.72
- HRMY $32.35
- Resistance Level
- SWI $13.97
- HRMY $33.66
- Average True Range (ATR)
- SWI 0.33
- HRMY 1.14
- MACD
- SWI -0.06
- HRMY -0.13
- Stochastic Oscillator
- SWI 25.19
- HRMY 15.24
About SWI SolarWinds Corporation
SolarWinds Corp is a provider of information technology (IT), and management software. Company offers full-stack observability solutions. The company's business is focused on building products that enable technology professionals and leaders to securely monitor and manage the performance of their IT environments, whether on-premises, in the cloud or in hybrid deployments. The products offered are designed to monitor and manage networks, systems, databases and applications across on-premises, multi-cloud and hybrid IT environments without the need for customization or professional services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.